All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020–2023
Long COVID was associated with non-negligible HCRU, direct and indirect costs to the French healthcare system. These findings reinforce the importance of optimizing long-term resource allocation for patients infected with SARS-CoV-2.
Authors
- S. Fiévez (ORCID: https://orcid.org/0009-0009-8013-2399)
- Hannah R. Volkman (ORCID: https://orcid.org/0000-0001-7274-9641)
- Cheikh Tamberou
- Jennifer L. Nguyen (ORCID: https://orcid.org/0000-0002-4064-0227)
- Jinma Ren (ORCID: https://orcid.org/0000-0002-4616-476X)
- Haifa Ben Romdhane (ORCID: https://orcid.org/0000-0002-5755-5117)
- Pierre-Alexandre Squara (ORCID: https://orcid.org/0000-0001-5998-8285)
- Jingyan Yang (ORCID: https://orcid.org/0000-0001-5523-649X)
- Pascal Crépey (ORCID: https://orcid.org/0000-0003-1852-0752)
- Olivier Robineau (ORCID: https://orcid.org/0000-0001-8196-5442)
- Elise Arnée
- Ayoub Boukhlal
- Marina Lepoutre-Bourguet
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- École des Hautes Études en Santé Publique (FR)
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Sorbonne Université (FR)
- Centre Hospitalier de Tourcoing (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Institute for Social and Economic Research (GB)
- Diagnostics for the Real World (United Kingdom) (GB)
- Université de Rennes (FR)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1080/13696998.2025.2485626
- Citations
- 3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Pfizer